Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian (Asia Pacific)
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian (Asia Pacific)
The Outer Worlds 2 review – improved space-faring sequel is an enjoyable time sink
3/11/2025
Richard Ashcroft : ‘Why not Sir Liam and Sir Noel ?’
3/11/2025
Want to know everything ? Perhaps it’s best if you don’t
3/11/2025
The one change that worked : I struggled with stress after work – until I made a discovery in my attic
3/11/2025
How Mortal Kombat (and moral panic) changed the gaming world
3/11/2025
Is it true that … consuming too much sugar can make you hyperactive ?
3/11/2025